WO2004062552A3 - Pharmaceutical composition containing a nsaid and a benzimidazole derivative - Google Patents

Pharmaceutical composition containing a nsaid and a benzimidazole derivative Download PDF

Info

Publication number
WO2004062552A3
WO2004062552A3 PCT/BE2004/000003 BE2004000003W WO2004062552A3 WO 2004062552 A3 WO2004062552 A3 WO 2004062552A3 BE 2004000003 W BE2004000003 W BE 2004000003W WO 2004062552 A3 WO2004062552 A3 WO 2004062552A3
Authority
WO
WIPO (PCT)
Prior art keywords
benzimidazole derivative
nsaid
pharmaceutical composition
composition containing
dosage form
Prior art date
Application number
PCT/BE2004/000003
Other languages
French (fr)
Other versions
WO2004062552A2 (en
Inventor
Francis Vanderbist
Antonio Sereno
Philippe Baudier
Original Assignee
Galephar M F
Francis Vanderbist
Antonio Sereno
Philippe Baudier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galephar M F, Francis Vanderbist, Antonio Sereno, Philippe Baudier filed Critical Galephar M F
Publication of WO2004062552A2 publication Critical patent/WO2004062552A2/en
Publication of WO2004062552A3 publication Critical patent/WO2004062552A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Abstract

The present invention provides an oral pharmaceutical dosage form consisting in a combination, in the same dosage form, of an enteric coated or controlled release coated pellets and/or tablets, and an enteric coated tablet of a benzimidazole derivative, both coatings presenting different release characteristics.
PCT/BE2004/000003 2003-01-09 2004-01-09 Pharmaceutical composition containing a nsaid and a benzimidazole derivative WO2004062552A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE0300004 2003-01-09
BEPCT/BE03/00004 2003-01-09

Publications (2)

Publication Number Publication Date
WO2004062552A2 WO2004062552A2 (en) 2004-07-29
WO2004062552A3 true WO2004062552A3 (en) 2004-10-14

Family

ID=32686673

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE2004/000003 WO2004062552A2 (en) 2003-01-09 2004-01-09 Pharmaceutical composition containing a nsaid and a benzimidazole derivative

Country Status (1)

Country Link
WO (1) WO2004062552A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852636B2 (en) 2001-06-01 2014-10-07 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8945621B2 (en) 2009-06-25 2015-02-03 Pozen Inc. Method for treating a patient at risk for developing an NSAID-associated ulcer
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04009698A (en) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Solid pharmaceutical formulations comprising diacereine and meloxicam.
AR057181A1 (en) * 2005-11-30 2007-11-21 Astra Ab NEW COMBINATION DOSAGE FORM
US20070154542A1 (en) * 2005-12-30 2007-07-05 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
WO2007129178A2 (en) * 2006-04-28 2007-11-15 Wockhardt Ltd Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic- analgesic drug and proton pump inhibitor
WO2008018825A1 (en) * 2006-08-10 2008-02-14 Astrazeneca Ab Oral polyvinyl alcohol capsules comprising proton pump inhibitors
US9095519B2 (en) * 2007-02-09 2015-08-04 Alphapharm Pty Ltd Dosage form containing two or more active pharmaceutical ingredients in different physical forms
CA2600147A1 (en) * 2007-06-11 2008-12-11 Nathan Bryson Combination for treatment of diabetes mellitus
CN104208039B (en) * 2014-08-26 2017-05-03 杭州新诺华医药有限公司 Naproxen esomeprazole enteric preparation and preparation method thereof
CA2977168C (en) * 2015-03-31 2020-01-28 Laboratorios Bago S.A. Enteric-coated pellets containing a proton pump inhibitor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025064A1 (en) * 1996-01-08 1997-07-17 Astra Aktiebolag Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
WO2002032425A2 (en) * 2000-10-20 2002-04-25 Galephar M/F Stable oral formulation containing benzimidazole derivative
WO2004060372A1 (en) * 2002-12-20 2004-07-22 Tap Pharmaceutical Products Inc. Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025064A1 (en) * 1996-01-08 1997-07-17 Astra Aktiebolag Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
WO2002032425A2 (en) * 2000-10-20 2002-04-25 Galephar M/F Stable oral formulation containing benzimidazole derivative
WO2004060372A1 (en) * 2002-12-20 2004-07-22 Tap Pharmaceutical Products Inc. Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANDERSSON T ET AL: "Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole", EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol. 54, no. 5, July 1998 (1998-07-01), pages 399 - 404, XP002292866, ISSN: 0031-6970 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852636B2 (en) 2001-06-01 2014-10-07 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8858996B2 (en) 2001-06-01 2014-10-14 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDS
US8865190B2 (en) 2001-06-01 2014-10-21 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9161920B2 (en) 2001-06-01 2015-10-20 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9198888B2 (en) 2001-06-01 2015-12-01 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9345695B2 (en) 2001-06-01 2016-05-24 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9364439B2 (en) 2001-06-01 2016-06-14 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
US9393208B2 (en) 2008-09-09 2016-07-19 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
US8945621B2 (en) 2009-06-25 2015-02-03 Pozen Inc. Method for treating a patient at risk for developing an NSAID-associated ulcer
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Also Published As

Publication number Publication date
WO2004062552A2 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
IL245365A0 (en) Modulators of atp-binding cassette transporters, pharmaceutical compositions containing the same and uses thereof
WO2004112756A8 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
EP2226074A3 (en) Pharmaceutical compositions and their methods of use
WO2007010034A3 (en) Ampholytic copolymer, production thereof, and use of the same
MY148867A (en) Gastric retention drug delivery system
AU5680100A (en) Controlled release and taste masking oral pharmaceutical compositions
MXPA04005011A (en) Capsule with fast content solubilization and release.
WO2005009381A3 (en) Immediate-release formulation of acid-labile pharmaceutical compositions
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
WO2003066030A3 (en) Pharmaceutical tablet
WO2008132710A3 (en) Pharmaceutical nimodipine compositions
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
EG25188A (en) Device for the packaging and dispensing of solid shaped bodies, especially oral tablets or/and capsules.
AU2003286994A1 (en) Modified release pharmaceutical composition
MX2007002898A (en) Tablets with site time-controlled gastrointestinal release of active ingredient.
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
WO2005123045A3 (en) Controlled release matrix pharmaceutical dosage formulation
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
WO2007075980A8 (en) Lansoprazole orally disintegrating tablets
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
IL163643A0 (en) Oxazolidinone derivatives, processes for their forpreparation, and pharmaceutical compositions containing them
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties
WO2004012722A3 (en) Bicifadine formulation
WO2010018175A3 (en) Oral pharmaceutical formulation for omeprazole comprising a specific separation layer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase